About

Dr. M. Durand is a leading urological surgeon and researcher whose work has fundamentally advanced the surgical management of prostate and kidney cancers. His primary research focuses on refining robotic-assisted surgery to optimize functional outcomes without compromising oncological control. Dr. Durand’s most significant contribution is the development of a risk-stratified, anatomical grading system for nerve-sparing during robot-assisted radical prostatectomy (RARP). This innovation, detailed in his highly cited 2011 paper (226 citations), moved the field beyond a one-size-fits-all approach, enabling surgeons to tailor the degree of nerve preservation to individual patient risk profiles. His subsequent work demonstrated that this technique significantly improves the early return of urinary continence (124 citations), a critical quality-of-life outcome. In kidney cancer, Dr. Durand has been instrumental in evaluating the oncological safety of different surgical approaches, including off-clamp partial nephrectomy and comparing outcomes in elderly patients. He is also at the forefront of surgical innovation, leading clinical trials on low-pressure insufflation to enhance patient recovery and pioneering the use of indocyanine green for intracorporeal urinary diversion during radical cystectomy.

Research Focus

Key Achievements

8
H-Index
14
Papers
489
Total Citations
35
Avg Citations/Paper
🏆 Most Cited Paper
Anatomical grades of nerve sparing: a risk‐stratified approach to neural‐hammock sparing during robot‐assisted radical prostatectomy (RARP)
226 citations · 2011
📈 Most Prolific Year: 2023 (3 Papers)
🤝 Key Collaborators: 120
🏛 Institutions: Prostate Cancer Foundation, Cornell University, NewYork–Presbyterian Hospital, Hôpital Pasteur, Centre National de la Recherche Scientifique, New York Hospital Queens

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago